These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3878415)

  • 1. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Sato K; Fukumoto T
    Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
    Jpn J Antibiot; 1986 Mar; 39(3):842-52. PubMed ID: 3488425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Haruta T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin].
    Etesse-Carsenti H; Caillon J; Mondain V; Durant J; Bernard E; Dellamonica P; Drugeon HB
    Pathol Biol (Paris); 1991 Sep; 39(7):658-67. PubMed ID: 1758716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I; Horiguchi S; Hatae T
    Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
    Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sunakawa K; Ishizuka Y
    Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Doern GV; Chapin KC
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial activities of clavulanic acid/amoxicillin against freshly isolated clinical strains from outpatients].
    Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Dec; 48(12):1920-34. PubMed ID: 8587166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sugita M; Takahashi T; Fukushima Y; Yamasaki M; Hori M
    Jpn J Antibiot; 1989 Jul; 42(7):1519-46. PubMed ID: 2810728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.